以前存在的干细胞异质性决定了对获得白血病驱动突变的克隆反应
Indranil Singh1, Daniel Fernandez-Perez2, Pedro Sanchez Sanchez2
1Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain; Facultat de Biologia, Universitat de Barcelona, Barcelona, Catalonia, Spain.
Cell stem cell
|February 26, 2025
概括
癌细胞的多样性源于不同的干细胞起源. 新的方法揭示了像Dnmt3a-R878H和Npm1c这样的突变如何改变干细胞行为,推动癌症进化和表型变异.
科学领域:
- 癌症生物学 癌症生物学
- 干细胞生物学 干细胞生物学
- 血液形成 血液形成 血液形成
背景情况:
- 癌细胞表现出显著的表型异质性,即使具有相同的突变.
- 原始细胞是一个潜在的因素,但目前的测试缺乏分辨率来区分干细胞和原始细胞子集.
- 了解早期癌症演变需要方法来跟踪与细胞状态有关的克隆动态和基因表达.
研究的目的:
- 开发一种新的方法来追踪癌症突变获得前后的克隆动态和基因表达.
- 研究特定白血病突变 (Dnmt3a-R878H,Npm1c) 对不同干细胞状态的影响.
- 阐明细胞史如何影响癌症表型和进化.
主要方法:
- 开发了同时跟踪复合酶激活和克隆动力学 (STRACK) 的方法.
- 通过STRACK,可以追踪克隆动态和基因表达.
- 使用具有特定白血病突变的小鼠模型来研究干细胞反应.
主要成果:
- Dnmt3a-R878H和Npm1c突变的影响在干细胞状态之间非常可变.
- 差异化原始干细胞的一个子集,通常超出竞争,在两种突变下扩大.
- Npm1c突变逆转了内在的血统偏差,使得分化原始干细胞能够产生更原始的恶性病态.
结论:
- 单细胞血统追踪对于了解早期癌症演变至关重要.
- 不同的细胞历史和状态赋予癌症不同的表型潜力.
- 原始细胞及其状态极大地影响癌症的发展和进展.
相关概念视频
02:40Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
01:22T Cell Activation and Clonal Selection
625
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
625
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K